Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
November 09, 2026
November 09, 2026
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
*
Research Highlights:
* In two, separate, year-long clinical trials, adults with moderate-to-severe sleep apnea and excess weight (BMI >=27 kg/m2) who took the oral GLP-1 medication orforglipron, had about 18 fewer breat . . .
* * *
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
*
Research Highlights:
* In two, separate, year-long clinical trials, adults with moderate-to-severe sleep apnea and excess weight (BMI >=27 kg/m2) who took the oral GLP-1 medication orforglipron, had about 18 fewer breat . . .